Envestors
VC Fund
London, United Kingdom
Envestors is a VC fund in London focused on Software and Manufacturing. Envestors’ digital investment platform brings together entrepreneurs and investors across geographies, communities and sectors – creating the single marketplace for early stage investment in the UK.We partner with accelerators, incubators and angel networks to provide a white-label platform empowering them to promote deals, engage investors andconnect to other networks.Founded in 2004, we have helped more than 200 high growth businesses raise more than £100m through our own private investment club.Envestors is authorised and regulated by the Financial Conduct Authority.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 44%
Last updated:
For AI agents: llms.txt
Industries Envestors invests in
Stages Envestors invests in
Countries Envestors invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Moleshead
|
|||
Ed Daubeney
|
|||
Nick Taylor
|
|||
Scott Haughton
|
|||
| See all 6 contacts → | |||
Investment Focus
Industry
- Software 4 (22%)
- Manufacturing 3 (17%)
- SaaS 2 (11%)
- FinTech 2 (11%)
- Medical 2 (11%)
Stage
- Funding Round 7 (39%)
- Seed 4 (22%)
- Series B 3 (17%)
- Angel 1 (6%)
- Series A 1 (6%)
Country
- United Kingdom 12 (67%)
- South Korea 2 (11%)
- Canada 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David Moleshead
Chairman
|
Chairman | Total investments: 0 | Find email | |
|
Ed Daubeney
Managing Director, Envestors Channel Islands
|
Managing Director, Envestors Channel Islands | Total investments: 0 | Find email | |
|
Nick Taylor
CFO and Co-Founder
|
CFO and Co-Founder | Total investments: 0 | Find email | |
Oliver Woolley
CEO & Co-founder
|
CEO & Co-founder | Total investments: 2 | Find email | |
|
Scott Haughton
COO/ Co-founder
|
COO/ Co-founder | Total investments: 1 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Willog
|
As a fast-growing startup, Willog provides a “item-level condition monitoring” that innovates the supply chain of sensitive, perishable or valuable goods where condition monitoring is required, and its efforts are to create a transparent and connected logistics flow. Based on its patented sensor technology and its cloud-based software, Willog helpscompanies gain seamless visibility down to the item-level and control over their shipments across their supply chain so they can have condition foresights and insights to improve their bottom line.Willog acquired 25 enterprise customers including MNCs like Hyundai Motor Group and DHL Express since its establishment. Willog is rapidly expanding its presence in various industries including bio-pharmaceutical, fresh food, and special logistics, where condition monitoring is key to business continuity. Going forward, while strengthening its leadership position in Korea, Willog will accelerate global expansion with partnerships in America, Kazakhstan, and Malaysia. | Series B / Oct 12, 2023 | |
AIMMO
|
AIMMO is the developer of a data annotation platform with custom workflow designs, labeler analytics, and real-time communication functions. The company was founded in 2016 by SeungTaek Oh and is headquartered in Seongnam-si, Gyeonggi-do, Republic of Korea. | $11M / Sep 06, 2023 | |
Clearco
|
Clearco is an online financial platform that provides growth capital to e-commerce and B2B companies. It utilizes proprietary software and data science models to identify high-growth funding opportunities and also offers funding in exchange for a steady revenue share of earnings. It also allows startups to avail an alternative source of funding fortheir fast-growing businesses without diluting equity. | $100M / Series C / Apr 20, 2021 | |
Libertine FPE
|
Libertine FPE designs and manufactures linear generator and piston power systems. | $1M / Apr 29, 2019 | |
Lightpoint Medical
|
Lightpoint Medical is an early-stage medical device company founded in 2012. The company is developing a breakthrough intraoperative imaging technology called Cerenkov Luminescence Imaging (CLI). CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the likelihood of cancer recurrence and the need for reoperation. | $6.5M / Series B / Dec 06, 2018 | |
Paint by Conran
|
Paint by Conran range is designed to help you make the most of your home. Conran’s designers live and breathe colour, and the colours chosen work beautifully with Conran’s furniture, lighting, textiles and accessories. Even better, the team have drawn on their expertise in architecture and interiors to ensure that the paints are practical anddurable. | $851K / Jul 27, 2015 | |
|
Lightpoint Medical
|
Lightpoint Medical is an early-stage medical device company founded in 2012. The company is developing a breakthrough intraoperative imaging technology called Cerenkov Luminescence Imaging (CLI). CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the likelihood of cancer recurrence and the need for reoperation. | $1.3M / Series A / Dec 30, 2014 | |
Ebury
|
Ebury is a financial technology company that offers international payment, foreign exchange, and business banking services. The company supports businesses engaged in cross-border trade and global operations. Its platform includes currency exchange, cash management, and trade finance tools. Ebury serves small and medium-sized enterprises as well aslarger organizations operating in multiple markets. | $4.6M / Sep 22, 2013 | |
Cipher Surgical
|
Cipher Surgical Limited is a medical device company established to design, patent and globally market a unique laparoscopic medical device for maintaining a clear distal window of the laparoscope during an operative procedure. | $1.6M / Seed / Feb 22, 2013 | |
OvuSense (Fertility Focus)
|
The OvuSense™ fertility monitoring family is designed for every step in your journey to pregnancy. From getting pregnant to getting help, we're with you every step of the way. The OvuSense family provides everything you need in ovulation and cycle monitoring to improve your chances of getting pregnant.Designed for your complete fertilityjourney, the OvuSense family works seamlessly with the OvuSense App to upload your data and provide you fertility updates in real time. | $1.6M / Jan 25, 2013 | |
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Envestors invest in?
Envestors invests primarily in Software, Manufacturing and SaaS startups, most often at Funding Round and Seed stage. Most of the 18 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Envestors?
Public channels for Envestors include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Envestors?
The team at Envestors includes David Moleshead (Chairman), Ed Daubeney (Managing Director, Envestors Channel Islands) and Nick Taylor (CFO and Co-Founder), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
